SEO URLwww.firestrike.ai/deals/rapt-therapeutics-gsk-acquisition-2026-11
acquisitionAnnounced · Jan 20, 2026BiotechnologySource · SpeculativeArticle · Factual
GSK acquires RAPT Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$2.2B
Target
RAPT Therapeutics
South San Francisco, California
Acquirer
GSK
Full Acquisition
Status
Announced
GSK agreed to acquire RAPT Therapeutics. Reported deal value: $2.2B. Status: Announced. Sector: Biotechnology. Target headquarters context: South San Francisco, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-20. Figures and status may change as filings and press coverage update.
Share SHARE British pharmaceutical company GlaxoSmithKline has agreed to acquire US biotech firm RAPT Therapeutics for $2.2 billion , gaining access to ozureprubart, a drug in development for food allergies
Deal timeline
Announced
Jan 20, 2026 · okaynews.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $2.2B. Figures and status may change as sources update.
Sources: okaynews.com · Primary article · FireStrike proprietary index